U.S. Approves First Device to Treat Depression with Brain Stimulation at Home

Scientific AmericanThursday, December 11, 2025 at 7:45:00 PM
PositiveScience
  • The U.S. Food and Drug Administration (FDA) has approved a groundbreaking device designed to treat depression through brain stimulation at home, targeting a specific brain region known for regulating mood. This marks a significant advancement in mental health treatment options, potentially allowing patients to manage their symptoms more effectively in a familiar environment.
  • The approval of this device represents a pivotal moment for mental health care, as it provides an innovative alternative to traditional therapies and medications. By enabling at-home treatment, it may enhance accessibility and adherence to treatment plans for individuals suffering from depression.
  • This development reflects a broader trend in the medical field towards utilizing technology for mental health interventions, paralleling other recent FDA approvals for devices aimed at addressing neurological conditions. The increasing focus on brain-computer interfaces and neurostimulation highlights the potential for technology to transform treatment paradigms in both mental and physical health.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
U.S. Sunscreens Aren’t Great. The FDA Could Soon Change That
PositiveScience
The U.S. Food and Drug Administration (FDA) is considering the approval of bemotrizinol, a highly effective UV filter that is widely used in sunscreen products across Europe and Asia. This potential change marks a significant shift in the U.S. sunscreen market, which has faced criticism for its limited range of effective UV filters.
Killer Whales and Dolphins May Team Up to Hunt Salmon
NeutralScience
Recent observations indicate that killer whales and dolphins may be collaborating to hunt salmon, showcasing a potential new behavior in marine mammal interactions. This teamwork could enhance their hunting efficiency and success rates in capturing prey.
Uterine Fibroids Significantly Raise Risk of Heart Disease
NegativeScience
A recent study published in Scientific American reveals that women diagnosed with uterine fibroids face an over 80 percent increased risk of developing heart disease over a decade compared to their peers. This significant finding highlights the potential health implications associated with these common growths.
Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis
NeutralScience
A new study has identified a mechanism by which mRNA COVID vaccines may, in rare instances, lead to myocarditis, a form of heart inflammation. This condition can also occur as a result of the COVID-19 disease itself, highlighting a potential link between vaccination and heart health concerns.
Improved ‘Terminator’ Sun Model Could Change Space Weather Forecasting
PositiveScience
An improved model of the sun's magnetic field, known as the terminator model, has been proposed, which could enhance the accuracy of space weather predictions. This advancement is expected to provide better insights into the sun's behavior and its impact on space weather phenomena.
How Animals Form Unlikely Alliances to Keep Predators Away
PositiveScience
Recent research highlights how animals form unlikely alliances, known as cross-species defense pacts, to effectively monitor and deter predators and parasites. These collaborations enhance their survival strategies in the wild, showcasing the complexity of animal interactions.
FDA Expands Covid Vaccine Inquiry to Adult Deaths
NegativeScience
The FDA has expanded its inquiry into the Covid vaccine to include adult deaths, claiming a link to 10 children's deaths associated with the vaccine, although it has not provided evidence to substantiate these claims. This development raises significant concerns regarding vaccine safety and public trust in health authorities.
RFK, Jr., Questions Safety of Approved RSV Shots for Babies
NeutralScience
FDA officials are currently reassessing several approved therapies for treating RSV in infants, despite previous clinical trials indicating these shots were safe. This scrutiny arises amid ongoing public discussions about vaccine safety and efficacy, particularly concerning childhood vaccinations.

Ready to build your own newsroom?

Subscribe once and get a personalised feed, podcast, newsletter, and notifications tuned to the topics you actually care about.